11/02/2019 19:00:00

Titan Pharmaceuticals Selects Life Sciences Business Intelligence CRM Innovator, TikaMobile, to Empower its Sales and MSL Teams

NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- TikaMobile, a premier cloud-based business intelligence  CRM provider for the life sciences industry, today announced that Titan Pharmaceuticals, Inc. has selected Tika’s BI/CRM platform to deliver real-time, actionable intelligence and interactive advanced analytics to its Sales and MSL teams. Titan is focused on the U.S. commercial relaunch of Probuphine® (buprenorphine) implant, its unique six-month maintenance treatment for Opioid Use Disorder (OUD).

With its unique ability to aggregate information and combine the functionality of disparate sales and marketing tools, TikaMobile will operate as Titan’s one-stop solution for its CRM and analytic needs. This will allow Titan to continue to strengthen its product launch process and leverage its Sales team to increase productivity and better drive revenue.  Titan’s MSL team will also have insights to better focus on KOLS to build stronger relationships and manage ongoing training initiatives with prescribers.

“We are pleased to be partnering with Titan as they work to change the medical landscape with their unique long-term maintenance treatment for opioid use disorder,” commented Manish Sharma, Chief Executive Officer and founder of TikaMobile. “Our advanced CRM and audience targeting capabilities will provide Titan with the intelligence and insights that their field reps need to increase their productivity, boost revenue generation and enhance the efficiency of their overall business practices.”

“Our field personnel appreciate the user-friendliness of the Tika system and the ability to view complex data in a simple and meaningful way,” said Titan’s EVP and Chief Commercial Officer, Dane Hallberg.  “We believe that Tika will provide our teams with a highly efficient way to identify opportunities, support our customers, and more-effectively manage our business in this competitive environment.”

About TikaMobile, Inc.

TikaMobile, Inc. is the premier leader in cloud-based business intelligence and CRM sales enablement software for the global life sciences industry. By combining many disparate sales and marketing tools into a single easy-to-use application, while applying prescriptive, actionable analytics across the commercial organization, Tika is transforming and optimizing sales organizations for pharmaceutical and medical device companies. Tika is committed to innovation, product excellence, and customer success and works with organizations of all sizes. Headquartered in New York City, Tika has offices in the United States, Europe and India. For more information, visit www.tikamobile.com.

About Titan Pharmaceuticals

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP), based in South San Francisco, CA, is a commercial stage company developing proprietary therapeutics with its ProNeura™ long-term, continuous drug delivery technology. The company's lead product is Probuphine® (buprenorphine) implant, a novel and long-acting formulation of buprenorphine for the long-term maintenance treatment of opioid dependence. Approved by the U.S. Food and Drug Administration in May 2016, Probuphine is the first and only commercialized treatment of opioid dependence to provide continuous, around-the-clock blood levels of buprenorphine for six months following a single procedure. The ProNeura technology also has the potential to be used in developing products for treating other chronic conditions such as Parkinson's disease and hypothyroidism, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes. For more information about Titan, please visit www.titanpharm.com

Contact: Robert Thomas | TikaMobile, Inc.

(646) 650-5545 | rthomas@tikamobile.com

 

Blogo_dark_tagline.jpg

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 Aug
VELO
Da flere skribenter stadig gerne vil beholde tråden for samling af de mange vigtige informationer o..
43
15 Aug
VELO
Det kunne tyde på at nogen mor modtaget receptal, der udviser netop det vi har talt om - at Envarsus..
37
19 Aug
OMXC25
Endnu en dansk patriark er død. Ære være hans minde.
26
18 Aug
 
Da Berlingske Media for cirka 1 år siden overtog Euroinvestor for 23 mio kr, meddelte de, at nu skul..
22
18 Aug
VELO
Fra anden skribent i Veloxis FB gruppen: Børsen side 4, søndag den 18. august. Et uddrag fra e..
20
16 Aug
I:NDX
16
14 Aug
TEVA
Ja, TEVA er jo bare en dårlig historie at købe ind i. I Danmark er aktien (som alle jo ved) primært ..
16
13 Aug
VELO
Til alle dem, som simpelthen ikke kan tro på det der sker lige foran næsen på dem.    Da jeg i sin b..
16
19 Aug
OMXC25
En fantastisk dygtig og sympatisk erhvervsmand.  Og en ægte patriot som også betalte sin skat med gl..
15
18 Aug
VELO
'83. Det er en god kommentar, iøvrigt har jeg kontaktet DDB i fredags for at høre om de læser recept..
15

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Photo Release -- WSFS Bank Welcomes Corynn Ciber in Newly Created Role, Chief Digital Officer
2
TTM Technologies, Inc. Announces Executive Transition
3
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eagle Bancorp, Karyopharm, L Brands, and National General and Encourages Investors to Contact the Firm
4
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mallinckrodt, Oasmia Pharmaceutical, Aclaris Therapeutics, and Curaleaf and Encourages Investors to Contact the Firm
5
Hagens Berman Investigating SAExploration Holdings (SAEX): Earnings Restatements, SEC Investigation, and Senior Executives Fired

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
20 August 2019 00:20:40
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB2 - 2019-08-20 01:20:40 - 2019-08-20 00:20:40 - 1000 - Website: OKAY